At the Western Medical Research Conference held this week in Carmel, California, UCSF’s Dr. Jackie Kading presented the latest results of clinical experience with Connect-EATM for birth defects involving the esophagus.
Dr. Kading’s talk compiled results from sixteen cases where Connect-EA was used. The cases were performed at leading children’s hospitals in the U.S. and Germany.
The neonates who underwent the Connect-EA procedure had concomitant conditions including single ventricle congenital heart disease, extreme prematurity, low birth weight and genetic syndromes.
Potential benefits for patients seen in analysis of the latest results with Connect-EA include sparing thoracotomy and protection against post-anastomotic stricture. The reduced rate of post-anastomotic stricture is particularly striking when compared to first-generation esophageal magnetic compression anastomosis (EMCA) systems.
Originally developed within the renowned Surgical Innovations program at the University of California at San Francisco, Connect-EA is now being transitioned to Myka Labs to spearhead the process of securing broad regulatory approvals and ensuring that Connect-EA is available to patients across the world who can potentially benefit from it.